Evolution of the Average Target: CME Group Inc.

Evolution of the Target Price: CME Group Inc.

Changes in Analyst Recommendations: CME Group Inc.

91aae814fc.6cMzCiha8jjcm6piDPEt17R1DbFOpQRTPfim9A_snKQ.2pFaMnEAlACa8-slU4UAves6OIQJkTUkDp6Wl3Waz8qBt15uUTGkWa743Q~4175170c2508ad91542d8584f09a06aa
04-29 Autonomous Research Adjusts Price Target on CME Group to $326 From $344, Maintains Outperform Rating MT
04-27 Rothschild & Co Redburn Adjusts Price Target on CME Group to $316 From $340, Maintains Neutral Rating MT
04-23 CME Sees Record Volumes Offset by Pricing Pressure; Data Services Momentum Remains Strong, RBC Says MT
04-23 CME Group Viewed as Strongest Liquidity Venue in Current Market, Morgan Stanley Says MT
04-23 Barclays Adjusts Price Target on CME Group to $316 From $343, Maintains Equalweight Rating MT
04-23 Deutsche Bank Lowers Price Target on CME Group to $322 From $342, Keeps Buy Rating MT
04-23 Goldman Sachs Adjusts Price Target on CME Group to $267 From $275, Maintains Sell Rating MT
04-23 Morgan Stanley Trims Price Target on CME Group to $353 From $362, Keeps Overweight Rating MT
04-23 JPMorgan Adjusts Price Target on CME to $273 From $271, Maintains Underweight Rating MT
04-23 TD Cowen Adjusts Price Target on CME to $323 From $340, Maintains Buy Rating MT
04-23 Barclays Adjusts Price Target on CME to $316 From $343, Maintains Equalweight Rating MT
04-16 JPMorgan Adjusts Price Target on CME Group to $271 From $266, Maintains Underweight Rating MT
04-15 Piper Sandler Adjusts Price Target on CME Group to $329 From $313, Maintains Overweight Rating MT
04-13 Rothschild & Co Redburn Adjusts CME Group Price Target to $340 From $347, Maintains Neutral Rating MT
04-09 Jefferies Adjusts Price Target on CME Group to $349 From $356, Maintains Buy Rating MT
04-09 TD Cowen Adjusts Price Target on CME to $340 From $328, Keeps Buy Rating MT
04-08 Barclays Adjusts Price Target on CME Group to $344 From $312, Maintains Equalweight Rating MT
04-07 Autonomous Research Adjusts Price Target on CME to $344 From $339, Maintains Outperform Rating MT
04-06 Raymond James Adjusts Price Target on CME Group to $320 From $310, Maintains Outperform Rating MT
03-16 Goldman Sachs Adjusts Price Target on CME to $275 From $266, Maintains Sell Rating MT
03-12 Rothschild & Co Redburn Adjusts Price Target on CME to $347 From $333, Maintains Neutral Rating MT
03-04 Argus Downgrades CME to Hold From Buy MT
03-02 Jefferies Adjusts Price Target on CME Group to $356 From $302, Maintains Buy Rating MT
02-12 Rothschild & Co Redburn Adjusts Price Target on CME Group to $333 From $300, Maintains Neutral Rating MT
02-11 Autonomous Research Adjusts Price Target on CME Group to $339 From $327, Maintains Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+2.99%
+24.6%
-4.92%
- +8.03%
-2.02%
+1.31%
-9.92%
+18.09%
+27.78%
- - +47.5%
Average +11.34%
Weighted average by Cap. +5.72%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
297.70USD
Average target price
306.60USD
Spread / Average Target
+2.99%
High Price Target
353.00USD
Spread / Highest target
+18.58%
Low Price Target
230.00USD
Spread / Lowest Target
-22.74%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Autonomous Research
Rothschild & Co Redburn
Barclays
Deutsche Bank Securities
Goldman Sachs
Morgan Stanley
JPMorgan Chase
TD Cowen
Piper Sandler
Jefferies & Co.
Raymond James
Argus
UBS
RBC Capital Markets
BofA Securities
Keefe Bruyette & Woods
Citigroup
Oppenheimer
Redburn Atlantic
Rosenblatt Securities
Keefe, Bruyette & Woods
Credit Suisse
Atlantic Equities
Berenberg Bank
Wells Fargo Securities
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
297.70USD
Average target price
306.60USD
Spread / Average Target
+2.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CME Stock
  4. Consensus CME Group Inc.